<DOC>
<DOCNO>
EP-0010896
</DOCNO>
<TEXT>
<DATE>
19800514
</DATE>
<IPC-CLASSIFICATIONS>
C07D-333/20 C07C-211/00 C07C-87/457 C07C-211/25 C07D-213/53 A61K-31/38 A61P-3/00 C07D-333/00 C07D-307/68 A61K-31/535 C07D-213/00 C07D-217/04 C07D-211/04 A61P-3/10 A61K-31/135 A61K-31/34 A61K-31/395 C07D-295/02 A61K-31/13 <main>C07C-87/28</main> C07D-295/096 C07C-217/00 A61K-31/275 C07C-211/29 C07C-255/58 C07D-213/38 C07D-209/44 C07D-295/135 C07C-217/58 C07D-307/52 A61P-3/08 C07D-217/00 C07D-401/00 C07D-307/00 C07D-295/155 C07C-255/00 C07D-295/00 C07D-213/82 A61K-33/02 C07C-211/27 C07D-295/073 C07D-209/00 A61K-31/381 C07D-401/12 
</IPC-CLASSIFICATIONS>
<TITLE>
organic diamine compounds for use as oral hypoglycemic agents and pharmaceutical compositions thereof.
</TITLE>
<APPLICANT>
pfizerus<sep>pfizer inc.<sep>pfizer inc.235 east 42nd streetnew york, n.y. 10017us<sep>pfizer inc.<sep>
</APPLICANT>
<INVENTOR>
belletire john lewis<sep>belletire, john lewis<sep>belletire, john lewis10b university houses madisoncounty of dane wisconsinus<sep>belletire, john lewis<sep>belletire, john lewis10b university houses madisoncounty of dane wisconsinus<sep>
</INVENTOR>
<ABSTRACT>
the compounds for use as oral hypoglycemic agents  are of the formulae:    or    wherein x is hydrogen, fluorine, chlorine, bromine, nitro,  cyano, lower alkyl or lower alkoxy, x being other than hy­ drogen in formula (i);   y and y′ are each amino, lower n-monoalkylamino,  lower n,n-dialkylamino, pyridylamino, pyrrolidino, piperi­ dino, homopiperidino, morpholino, thiomorpholino, 2,3-di­ hydroisoindolyl and 1,2,3,4-tetrahydroisoquinolyl; and   z is oxygen or sulfur.  several methods for the prepa­ ration of these compounds are described; e. g.  α,α′-dibro­ mo-o-xylene by reaction with piperidine gives 1,1′-[1,2-­ phenylene-bis-(methylene)]bispiperidine.  novel compounds claimed are: those of formula (i)  wherein x is other than hydrogen or methyl, or wherein y  is pyridylamino and y′ is other than pyridylamino; and the  compounds of formulae (iv) and (vi).  compositions claim­ ed comprise an effective blood sugar lowering amount of a  compound of formulae (i) to (vi) and a carrier material.  
</ABSTRACT>
</TEXT>
</DOC>
